Bevacizumab in Mesothelioma



The overall survival benefit seen with addition of bevacizumab to cisplatin/pemetrexed in patients with mesothelioma is practice-changing, according to Naiyer Rizvi, MD. The panelists discuss the data presented at ASCO 2015.

source

https://ift.tt/2Bmv7lp

Comments

Popular posts from this blog

Maryland Mesothelioma Attorneys

What is Asbestos? What to do if exposed to asbestos? Call Belluck & Fox: (212) 681-1575